Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Metis Global Partners LLC

Metis Global Partners LLC lessened its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 2.8% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 4,426 shares of the biotechnology company’s stock after selling 127 shares during the quarter. Metis Global Partners LLC’s holdings in Axon Enterprise were worth $2,630,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Prestige Wealth Management Group LLC raised its holdings in Axon Enterprise by 115.8% in the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after purchasing an additional 44 shares during the period. New Wave Wealth Advisors LLC acquired a new position in Axon Enterprise in the 4th quarter worth about $40,000. Brooklyn Investment Group acquired a new position in Axon Enterprise in the 3rd quarter worth about $41,000. Y.D. More Investments Ltd acquired a new position in Axon Enterprise in the 4th quarter worth about $45,000. Finally, Planning Capital Management Corp raised its holdings in Axon Enterprise by 83.3% in the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after purchasing an additional 55 shares during the period. Institutional investors and hedge funds own 79.08% of the company’s stock.

Analyst Ratings Changes

A number of research firms recently weighed in on AXON. Craig Hallum cut Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 price target for the company. in a report on Thursday, February 20th. Northland Securities upped their price target on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a report on Monday, November 11th. Robert W. Baird boosted their price objective on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. Barclays set a $726.00 price objective on Axon Enterprise and gave the stock an “overweight” rating in a research note on Thursday. Finally, JMP Securities reiterated an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. Three investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat, Axon Enterprise currently has an average rating of “Moderate Buy” and a consensus price target of $587.38.

Insider Activity

In related news, Director Michael Garnreiter sold 1,000 shares of the stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $639.69, for a total value of $639,690.00. Following the completion of the transaction, the director now directly owns 24,259 shares in the company, valued at approximately $15,518,239.71. This represents a 3.96 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Julie A. Cullivan sold 1,261 shares of the stock in a transaction that occurred on Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total value of $860,077.66. Following the completion of the transaction, the director now owns 2,392 shares of the company’s stock, valued at $1,631,487.52. The trade was a 34.52 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 8,711 shares of company stock worth $5,631,561 over the last ninety days. Corporate insiders own 6.10% of the company’s stock.

Axon Enterprise Price Performance

AXON stock opened at $528.45 on Friday. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The business has a 50 day simple moving average of $609.55 and a 200-day simple moving average of $524.28. The firm has a market capitalization of $40.30 billion, a PE ratio of 136.55, a price-to-earnings-growth ratio of 5.17 and a beta of 1.05. Axon Enterprise, Inc. has a 1 year low of $273.52 and a 1 year high of $715.99.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.